Lindsay A Md Rosenwald is PRESIDENT, CEO & CHAIRMAN of Fortress Biotech, Inc.. Currently has a direct ownership of 3.66 Million shares of FBIO, which is worth approximately $6.95 Million. The most recent transaction as insider was on Jun 01, 2020, when has been sold 1,602 shares (Common Stock, par value $0.001) at a price of $1.69 per share, resulting in proceeds of $2,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.66M
2768.44% 3M change
76.33% 12M change
Total Value Held $6.95 Million

LINDSAY A MD ROSENWALD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2020
BUY
Grant, award, or other acquisition
$2,707 $1.69 p/Share
1,602 Added 0.02%
9,375,450 Common Stock, par valu...

Also insider at

CKPT
Checkpoint Therapeutics, Inc. Healthcare
DERM
Journey Medical Corp Healthcare
MBIO
MUSTANG BIO, INC. Healthcare
ATXI
AVENUE THERAPEUTICS, INC. Healthcare
LAM

Lindsay A Md Rosenwald

PRESIDENT, CEO & CHAIRMAN
Scottsdale, AZ

Track Institutional and Insider Activities on FBIO

Follow Fortress Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBIO shares.

Notify only if

Insider Trading

Get notified when an Fortress Biotech, Inc. insider buys or sells FBIO shares.

Notify only if

News

Receive news related to Fortress Biotech, Inc.

Track Activities on FBIO